Flosequinan for Heart Failure
Flosequinan (Manoplax - Boots), a fluoroquinolone derivative, is now available in the USA for treatment of congestive heart failure. Labeling approved by the US Food and Drug Administration recommends the drug only for patients who cannot tolerate or have not responded adequately to an angiotensin-converting enzyme (ACE) inhibitor....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Flosequinan for Heart Failure
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 892
Article Code: 892a
Date: March 19, 1993
Volume: 35
Pages: 23-24
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 892
Article Code: 892a
Date: March 19, 1993
Volume: 35
Pages: 23-24
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)